Komori
Kimura Chemical Plants (6378) · InitiativeRestated

Risk management under the Board of Directors Rules, Management Committee Regulations and approval authority regulations

First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2026.

4entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20262019: 120192020: 120202021: 120212022: 020222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Rules-based risk management by the Board of Directors and Administration DivisionA theme 32 companies write about · 0 as a headwind · 28 as a tailwind

The whole theme swung hardest in 2022: 2 of 16 companies on the "Worse" side.

23 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 32 companies compared. The sentences above are computed from all 32.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「For important management issues, the Company submits all matters to the Board of Directors and the Management Committee in accordance with the Board of Directors Rules, Management Committee Regulations and approval authority regulations, and deliberates their rationale, anticipated risks and response measures.」

    The Company continues its system of submitting important matters to the Board of Directors and the Management Committee and deliberating risks under the approval authority regulations and consultation with relevant departments.
  2. FY2021RestatedAnnual report

    「For important management issues, the Company submits all matters to the Board of Directors and the Management Committee in accordance with the Board of Directors Rules, Management Committee Regulations and approval authority regulations, and deliberates their rationale, anticipated risks and response measures.」

    The Company continues its system of submitting important matters to the Board of Directors and the Management Committee and deliberating risks under the approval authority regulations and consultation with relevant departments.
  3. FY2020RestatedAnnual report

    「At the Company, important management issues are submitted without omission to the Board of Directors and the Management Committee in accordance with the Board of Directors Rules, Management Committee Regulations and approval authority regulations, and their rationale, anticipated risks and response measures are deliberated.」

    The Company continues its system of submitting important matters to the Board of Directors and the Management Committee and deliberating risks under the approval authority regulations and consultation with relevant departments.
  4. FY2019First statedAnnual report

    「For important management issues, the Company submits all matters to the Board of Directors and the Management Committee in accordance with the Board of Directors Rules, Management Committee Regulations and approval authority regulations, and deliberates their rationale, anticipated risks and response measures.」

    The Company describes for the first time as a separate theme a system under which important matters are submitted to the Board of Directors and the Management Committee, with risks anticipated and mitigated through the approval authority regulations and consultation with relevant departments.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kimura Chemical Plants yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.